Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 19 studies | 49% ± 22% | |
glutamatergic neuron | 6 studies | 38% ± 17% | |
natural killer cell | 5 studies | 20% ± 4% | |
enterocyte | 5 studies | 24% ± 5% | |
GABAergic neuron | 5 studies | 31% ± 16% | |
mucosal invariant T cell | 5 studies | 19% ± 3% | |
CD16-negative, CD56-bright natural killer cell, human | 5 studies | 25% ± 5% | |
endothelial cell of vascular tree | 5 studies | 39% ± 18% | |
vein endothelial cell | 4 studies | 35% ± 25% | |
renal principal cell | 4 studies | 26% ± 6% | |
pancreatic A cell | 3 studies | 22% ± 5% | |
gamma-delta T cell | 3 studies | 25% ± 4% | |
interneuron | 3 studies | 42% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 40% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 26922.88 | 258 / 258 | 97% | 57.44 | 224 / 230 |
brain | 99% | 1795.56 | 2624 / 2642 | 97% | 16.07 | 684 / 705 |
liver | 100% | 1649.60 | 226 / 226 | 86% | 27.64 | 348 / 406 |
kidney | 100% | 1711.75 | 89 / 89 | 83% | 42.90 | 751 / 901 |
prostate | 99% | 1020.65 | 242 / 245 | 75% | 5.71 | 374 / 502 |
intestine | 95% | 2106.41 | 919 / 966 | 72% | 17.22 | 379 / 527 |
thymus | 97% | 739.63 | 631 / 653 | 41% | 2.25 | 251 / 605 |
stomach | 64% | 285.43 | 231 / 359 | 65% | 13.08 | 186 / 286 |
breast | 96% | 1330.47 | 441 / 459 | 30% | 1.90 | 340 / 1118 |
esophagus | 91% | 453.38 | 1314 / 1445 | 28% | 1.70 | 51 / 183 |
uterus | 99% | 1839.78 | 168 / 170 | 15% | 1.06 | 67 / 459 |
bladder | 76% | 516.10 | 16 / 21 | 26% | 4.66 | 132 / 504 |
pancreas | 32% | 116.52 | 106 / 328 | 69% | 11.23 | 122 / 178 |
spleen | 100% | 699.10 | 241 / 241 | 0% | 0 | 0 / 0 |
lung | 76% | 439.67 | 438 / 578 | 16% | 1.13 | 181 / 1155 |
adipose | 88% | 624.73 | 1065 / 1204 | 0% | 0 | 0 / 0 |
ovary | 87% | 496.16 | 156 / 180 | 1% | 0.13 | 6 / 430 |
skin | 24% | 78.45 | 439 / 1809 | 22% | 1.53 | 105 / 472 |
heart | 46% | 202.53 | 392 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 39% | 186.64 | 362 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 32% | 138.30 | 424 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 31% | 6.85 | 9 / 29 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.66 | 7 / 45 |
muscle | 1% | 1.61 | 5 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0055085 | Biological process | transmembrane transport |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_0070633 | Biological process | transepithelial transport |
GO_1990962 | Biological process | xenobiotic transport across blood-brain barrier |
GO_0047484 | Biological process | regulation of response to osmotic stress |
GO_1990961 | Biological process | xenobiotic detoxification by transmembrane export across the plasma membrane |
GO_0140115 | Biological process | export across plasma membrane |
GO_1905039 | Biological process | carboxylic acid transmembrane transport |
GO_1901529 | Biological process | positive regulation of anion channel activity |
GO_0046865 | Biological process | terpenoid transport |
GO_0045332 | Biological process | phospholipid translocation |
GO_0099040 | Biological process | ceramide translocation |
GO_0000086 | Biological process | G2/M transition of mitotic cell cycle |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_2001225 | Biological process | regulation of chloride transport |
GO_0072089 | Biological process | stem cell proliferation |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0098591 | Cellular component | external side of apical plasma membrane |
GO_0009986 | Cellular component | cell surface |
GO_0005737 | Cellular component | cytoplasm |
GO_0046943 | Molecular function | carboxylic acid transmembrane transporter activity |
GO_0090554 | Molecular function | phosphatidylcholine floppase activity |
GO_0015562 | Molecular function | efflux transmembrane transporter activity |
GO_0008559 | Molecular function | ABC-type xenobiotic transporter activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0099038 | Molecular function | ceramide floppase activity |
GO_0042910 | Molecular function | xenobiotic transmembrane transporter activity |
GO_0090555 | Molecular function | phosphatidylethanolamine flippase activity |
GO_0140328 | Molecular function | floppase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0042626 | Molecular function | ATPase-coupled transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
GO_0022857 | Molecular function | transmembrane transporter activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | ABCB1 |
Protein name | ATP-binding cassette, sub-family B (MDR/TAP), member 1 Multidrug resistance protein 1 ATP binding cassette subfamily B member 1 ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243) p-glycoprotein 1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 (Multidrug resistance protein 1) Uncharacterized protein ABCB1 |
Synonyms | tcag7.316 hCG_20818 PGY1 MDR1 |
Description | FUNCTION: Translocates drugs and phospholipids across the membrane . Catalyzes the flop of phospholipids from the cytoplasmic to the exoplasmic leaflet of the apical membrane. Participates mainly to the flop of phosphatidylcholine, phosphatidylethanolamine, beta-D-glucosylceramides and sphingomyelins . Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells . . |
Accessions | ENST00000416177.1 F4ZUQ5 F4ZUV4 B5U2G4 F4ZUV0 F4ZV79 F4ZUT2 ENST00000543898.5 [P08183-2] Q6TBL4 F4ZUX9 A1L471 A8E2S6 ENST00000265724.8 [P08183-1] ENST00000622132.5 [P08183-1] E7EWT8 F4ZUY5 P08183 A4D1D2 |